12:00 AM
 | 
Oct 18, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Visudyne verteporfin: Phase III data; under FDA and EMEA review

Johns Hopkins researchers and colleagues published in the Archives of Ophthalmology data from QLT and partner Ciba Vision Corp.'s previously reported Phase III studies involving a total...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >